Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

KITTEE TRC20 Token Ad

CYCCP Quote Trading Chart Cyclacel Pharmaceuticals Inc. 6%...


home / stock / cyccp / cyccp quote

$6.41 Last:

-1.38% Change Percent:

$6.88 Open:

$6.50 Previous Close:

$6.88 High:

$6.05 Low:

7,637 Volume:

12/31/1969 07:00:00 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

CYCCP Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2022-08-116.886.56.886.057,637
2022-08-106.56.56.56.5156
2022-07-1477.00017.00017477
2022-07-137777271
2022-07-117.767.767.767.76185
2022-07-087.727.757.757.72422
2022-06-246.776.776.776.77331
2022-06-206.716.716.716.71106
2022-06-176.716.716.716.71106
2022-06-166.136.136.136.12601
2022-06-086.486.16.486.1610
2022-06-037.127.127.127.12301
2022-05-2477.17.17520
2022-05-106.486.486.486.48100
2022-05-096.486.486.486.48100
2022-05-066.486.486.486.48103
2022-05-046.356.356.356.35152
2022-05-026.26016.286.296.2601502
2022-04-287.156.357.156.35200
2022-04-266.926.926.926.92100
Stock Information

Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock Company Name:

CYCCP Stock Symbol:

NASDAQ Market:

MENU
CYCCP CYCCP Quote CYCCP Short CYCCP News CYCCP Articles CYCCP Message Board
Get CYCCP Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

Connect Twitter with Market Wire News
RECENT CYCCP NEWS
  • CYCCP - Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

    - Oral fadraciclib demonstrated good tolerability with continuous dosing; anticipate entering Phase 2 POC stage in 2H 2022 – - Demonstrated evidence of target engagement for CDK2 and CDK9 – - Company to host R&D day in ...

  • CYCCP - Cyclacel Pharmaceuticals to Release Second Quarter 2022 Financial Results

    BERKELEY HEIGHTS, N.J., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce second quarter 2022 financial results ...

  • CYCCP - Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline

    - Completed Enrollment in Phase 1 Dose Escalation with Oral Fadraciclib in Solid Tumors - - No Dose Limiting Toxicities Observed at All Dose Levels Enrolled to Date - - Demonstrated Evidence of Target Engagement for CDK2 and CDK9 - - Early Anticancer Activity...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Join us on Telegram

Join us on Telegram

Join the Trending Stocks News on Telegram to get immediate news notifications!

Telegram


Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2022 Market Wire News